Cargando…

Paraoxonase 1 and Non-Alcoholic Fatty Liver Disease: A Meta-Analysis

Oxidative stress is involved in the pathophysiology of nonalcoholic fatty liver disease (NAFLD). However, reliable biomarkers of NAFLD in relation to oxidative stress are not available. While paraoxonase 1 (PON1) is an antioxidant biomarker, there appears to be mixed data on PON-1 in patients with N...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kotani, Kazuhiko, Watanabe, Jun, Miura, Kouichi, Gugliucci, Alejandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8072946/ https://www.ncbi.nlm.nih.gov/pubmed/33923656 http://dx.doi.org/10.3390/molecules26082323

Ejemplares similares

Paraoxonase 1 and Chronic Kidney Disease: A Meta-Analysis
por: Watanabe, Jun, et al.
Publicado: (2023)

Paraoxonase 1 and Chronic Obstructive Pulmonary Disease: A Meta-Analysis
por: Watanabe, Jun, et al.
Publicado: (2021)

Paraoxonase 1 Activity and Renal Replacement Therapy for Chronic Renal Failure: A Meta-Analysis
por: Watanabe, Jun, et al.
Publicado: (2023)

Paraoxonase 1 in Chronic Kidney Failure
por: Gugliucci, Alejandro, et al.
Publicado: (2012)

Serum paraoxonase activity in familial hypercholesterolaemia
por: Kotani, Kazuhiko, et al.
Publicado: (2023)

Paired Measurements of Paraoxonase 1 and Serum Amyloid A as Useful Disease Markers
por: Kotani, Kazuhiko, et al.
Publicado: (2013)

Paraoxonase 1, HDL Subclasses and Post Surgery Acute Inflammation: A Pilot Study
por: Bains, Yasmin, et al.
Publicado: (2019)

Paraoxonase-1 Serum Concentration and PON1 Gene Polymorphisms: Relationship with Non-Alcoholic Fatty Liver Disease
por: Milaciu, Mircea Vasile, et al.
Publicado: (2019)

Oxidized High-Density Lipoprotein Shows a Stepwise Increase as Fibrosis Progresses in Patients with Nonalcoholic Fatty Liver Disease
por: Miura, Kouichi, et al.
Publicado: (2021)

Serum Paraoxonase as an Indicator for Fatty Liver in Sheep
por: Cao, Yu, et al.
Publicado: (2017)

Changes on the Physiological Lactonase Activity of Serum Paraoxonase 1 by a Diet Intervention for Weight Loss in Healthy Overweight and Obese Women
por: Kotani, Kazuhiko, et al.
Publicado: (2009)

Utility of FibroScan-based scoring systems to narrow the risk group of nonalcoholic fatty liver disease with comorbidities
por: Miura, Kouichi, et al.
Publicado: (2022)

Cytokines, paraoxonase-1, periostin and non-invasive liver fibrosis scores in patients with non-alcoholic fatty liver disease and persistently elevated aminotransferases: A pilot study
por: Milaciu, Mircea Vasile, et al.
Publicado: (2021)

Pemafibrate therapy for non-alcoholic fatty liver disease is more effective in lean patients than obese patients
por: Shinozaki, Satoshi, et al.
Publicado: (2022)

Similarity and differences in small dense low-density lipoprotein assessment: two methods compared
por: Kotani, Kazuhiko, et al.
Publicado: (2021)

Metabolic dysfunction-associated fatty liver disease reflects a significantly higher risk of hypertension than non-alcoholic fatty liver disease
por: Uehara, Tatsuki, et al.
Publicado: (2023)

Serum paraoxonase-1 as biomarker for improved diagnosis of fatty liver in dairy cows
por: Farid, Ayman Samir, et al.
Publicado: (2013)

Paraoxonase Activity and Expression Is Modulated by Therapeutics in Experimental Rat Nonalcoholic Fatty Liver Disease
por: Hussein, O., et al.
Publicado: (2012)

Gamma-glutamyl transferase and oxidised high-density lipoprotein: a pilot study
por: Kotani, Kazuhiko, et al.
Publicado: (2020)

Smoking and oxidised high-density lipoprotein: a preliminary report
por: Kotani, Kazuhiko, et al.
Publicado: (2021)

Paraoxonase/Arylesterase Activity of Serum Paraoxonase-1 and Schizophrenia: A Systematic Review and Meta-Analysis
por: Zinellu, Angelo, et al.
Publicado: (2023)

Autophagy in non-alcoholic fatty liver disease and alcoholic liver disease()
por: Khambu, Bilon, et al.
Publicado: (2018)

Performance of Fatty Liver Index in Identifying Non-Alcoholic Fatty Liver Disease in Population Studies. A Meta-Analysis
por: Castellana, Marco, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease
por: Sattar, Naveed, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease
por: Neuschwander-Tetri, Brent A.
Publicado: (2017)

Relationship between non-alcoholic fatty liver disease and inflammation in patients with non-alcoholic fatty liver
por: Foroughi, Mehdi, et al.
Publicado: (2016)

Alcohol? Not for Non-alcoholic Fatty Liver Disease Patients
por: Cainelli, Francesca, et al.
Publicado: (2020)

An analysis of polygenic risk scores for non-alcoholic fatty liver disease
por: Jun, Dae Won
Publicado: (2021)

Association of serum ferritin with non-alcoholic fatty liver disease: a meta-analysis
por: Du, Shui-Xian, et al.
Publicado: (2017)

Precision Medicine in Fatty Liver Disease/Non-Alcoholic Fatty Liver Disease
por: Valenzuela-Vallejo, Laura, et al.
Publicado: (2023)

Fatty Liver Disease and Non-Alcoholic Fatty Liver Disease Worsen the Outcome in Acute Pancreatitis: A Systematic Review and Meta-Analysis
por: Váncsa, Szilárd, et al.
Publicado: (2020)

Comparison of Outcomes Between Metabolic Dysfunction-Associated Fatty Liver Disease and Non-alcoholic Fatty Liver Disease: A Meta-Analysis
por: Virk, Ghazala S, et al.
Publicado: (2023)

Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
por: Wu, Dongqing, et al.
Publicado: (2021)

Non-alcoholic fatty liver disease and liver secretome
por: Khan, Muhammad Sohaib, et al.
Publicado: (2022)

Increased risk of cerebrovascular accident related to non-alcoholic fatty liver disease: a meta-analysis
por: Hu, Jianping, et al.
Publicado: (2017)

Effectiveness of One-Year Pemafibrate Therapy on Non-Alcoholic Fatty Liver Disease Refractory to Long-Term Sodium Glucose Cotransporter-2 Inhibitor Therapy: A Pilot Study
por: Shinozaki, Satoshi, et al.
Publicado: (2023)

The Effects of Modest Alcohol Consumption on Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
por: Wongtrakul, Wasit, et al.
Publicado: (2021)

Clinical assessment and management of liver fibrosis in non-alcoholic fatty liver disease
por: Campos-Murguía, Alejandro, et al.
Publicado: (2020)

Serum aspirin esterase is strongly associated with glucose and lipids in healthy subjects: different association patterns in subjects with type 2 diabetes mellitus
por: Kotani, Kazuhiko, et al.
Publicado: (2010)

Treatment of non-alcoholic fatty liver disease
por: Tolman, Keith G, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_v2efhb0coifup23sehdsqr66ml